The Role of Potassium-Binding Agents in Treating Hyperkalemia

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Related Videos
Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Medical care team | Image credit: Iryna - stock.adobe.com
Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com
Healthcare technology | Image credit: ipopba | stock.adobe.com
Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.